Doctor Massimo Mapelli

Doctor Massimo Mapelli

Monzino Cardiology Centre, Milan (Italy)

I'm a cardiologist involved in a PhD program with a deep interest in heart failure, exercise pathophysiology and Cardiomyopathies. I attended the 3rd PCHF course in Zurich. I work with a large Ugandan non-profit hospital. I think that multi-level (clinical and research) collaboration in the field of heart failure is a fundamental and priority goal

Presentations

Dapagliflozin effect on cardiopulmonary function in HFrEF patients

Event: ESC Preventive Cardiology 2024

Topic: Pharmacotherapy

Session: Effective treatment of heart failure

Access

Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study

Event: Heart Failure 2022

Topic: Hypertrophic Cardiomyopathy

Session: Highlight on cardiomyopathy

Access

Brisk walking can be a maximal effort in heart failure patients. A comparison of cardiopulmonary exercise and six-minute walking test cardiorespiratory data

Event: Heart Failure 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Heart Failure ePosters - focus on Chronic Heart Failure 2

Access

Vaccination for COVID-19 and cardiovascular risk prevention.

Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Influenza, COVID-19, vaccinations, and cardiovascular risk

Access

Feasibility of remote home monitoring with a T-shirt wearable device in post-recovery COVID-19 patients

Event: Heart Failure 2021

Topic: Remote Patient Monitoring and Telehealth

Session: ePoster session

Access

Old therapies of new fashion: a better way to use diuretics and normal saline in acute decompensated heart failure

Event: Heart Failure 2019

Topic: Nonpharmacological Treatment

Session: Clinical Case Corner 4 - Have you seen this before? Rare presentations

Access

Sacubitril/Valsartan use in a real world experience: data from a large single-center population of heart failure patients with reduced ejection fraction

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access

Effects of sacubitril/valsartan on cardiac performance and exercise capacity

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access

Prognostic role of diabetes and of medium-term glycemic control in heart failure

Event: Heart Failure 2019

Topic: Comorbidities

Session: Chronic Heart Failure - Clinical

Access

From kidney to kidney: an unusual case of paradoxical embolism through a patent foramen ovale in the course of a massive pulmonary embolism

Event: EuroEcho-Imaging 2018

Topic: Imaging of Congenital Heart Disease

Session: Imaging: Congenital Heart Disease

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Massimo Mapelli

Biography

Contributor content

Dapagliflozin effect on cardiopulmonary function in HFrEF patients

Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study

Brisk walking can be a maximal effort in heart failure patients. A comparison of cardiopulmonary exercise and six-minute walking test cardiorespiratory data

Vaccination for COVID-19 and cardiovascular risk prevention.

Feasibility of remote home monitoring with a T-shirt wearable device in post-recovery COVID-19 patients

Old therapies of new fashion: a better way to use diuretics and normal saline in acute decompensated heart failure

Sacubitril/Valsartan use in a real world experience: data from a large single-center population of heart failure patients with reduced ejection fraction

Effects of sacubitril/valsartan on cardiac performance and exercise capacity

Prognostic role of diabetes and of medium-term glycemic control in heart failure

From kidney to kidney: an unusual case of paradoxical embolism through a patent foramen ovale in the course of a massive pulmonary embolism

ESC 365 is supported by

Doctor Massimo Mapelli Follow

Biography

Contributor content

Dapagliflozin effect on cardiopulmonary function in HFrEF patients

Exercise oxygen kinetic in hypertrophic cardiomyopathy: results from a multicenter cardiopulmonary exercise testing study

Brisk walking can be a maximal effort in heart failure patients. A comparison of cardiopulmonary exercise and six-minute walking test cardiorespiratory data

Vaccination for COVID-19 and cardiovascular risk prevention.

Feasibility of remote home monitoring with a T-shirt wearable device in post-recovery COVID-19 patients

Old therapies of new fashion: a better way to use diuretics and normal saline in acute decompensated heart failure

Sacubitril/Valsartan use in a real world experience: data from a large single-center population of heart failure patients with reduced ejection fraction

Effects of sacubitril/valsartan on cardiac performance and exercise capacity

Prognostic role of diabetes and of medium-term glycemic control in heart failure

From kidney to kidney: an unusual case of paradoxical embolism through a patent foramen ovale in the course of a massive pulmonary embolism

ESC 365 is supported by

Doctor Massimo Mapelli